Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DnaJ homolog subfamily C member 9 (DNAJC9) is a multifunctional co-chaperone protein that acts as both a heat shock co-chaperone (Hsp40 family) and a histone chaperone. It forms complexes with histone H3–H4 and other factors like MCM2 to promote correct folding of newly synthesized histones. DNAJC9 is essential for replication- and transcription-coupled nucleosome assembly, helping resolve aberrant histone intermediates and protecting chromatin integrity[1][2][3]. It functions as an integrator of ATP-dependent HSP70 enzyme activity—directing chaperone machinery to histones H3–H4 and maintaining their structural integrity during proteostasis processes[1][3]. DNAJC9 is primarily localized to the cytosol and nucleoplasm and plays roles in protein folding, chromatin assembly, and the positive regulation of ATP-dependent processes. Dysregulated DNAJC9 expression has been observed in neuropsychiatric conditions, implicating a broader role in nuclear protein homeostasis and transcriptional regulation[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DnaJ homolog subfamily C member 9 (DNAJC9).